tm logo
OMEROS
SEARCHED

on 04 Nov 2024

Last Applicant/ Owned by

OMEROS CORPORATION

201 Elliott Avenue WestSeattle WA 98119

US

Serial Number

2269208 filed on 26th Apr 2023

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

OMEROS

Trademark usage description

biological and pharmaceutical preparations for the treatment of transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiov Read More

Classification Information


Class [005]
Biological and pharmaceutical preparations for the treatment of transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders.


Classification kind code

12

Class [042]
Providing information about medical research, namely, providing information about the results of clinical trials for pharmaceutical products, medical and scientific research with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders.


Classification kind code

12

Mark Details


Serial Number

2269208

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 04th Nov 2024
Search Recorded
Submitted for opposition 20
on 04th Nov 2024
Examiner's First Report
Submitted for opposition 223
on 04th Nov 2024
Total Provisional Refusal
Submitted for opposition 256
on 13th May 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 03rd Aug 2023
Agent Changed
Submitted for opposition 257
on 13th Jul 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 12th Jul 2023
Formalized
Submitted for opposition 1
on 12th Jul 2023
Created
Submitted for opposition 228
on 26th Apr 2023
International Registration
Submitted for opposition 30
on 26th Apr 2023
Filed